Modelling the dynamics of pentachlorophenol bioavailability in column experiments
Related Experiment Video
Updated: Aug 23, 2026

Post Column Derivatization Using Reaction Flow High Performance Liquid Chromatography Columns
Published on: April 26, 2016
Yves Dudal1, Astrid R Jacobson, Réjean Samson
1Chemical Engineering Department, Ecole Polytechnique de Montréal, P.O. Box 6079, Centre-Ville Station, Montréal, Québec, H3C 3A7, Canada.
Abstract:
The aqueous-phase concentration of an organic pollutant found in a subsurface environment is often assumed to be its bioavailable concentration. However, the aqueous-phase concentration does not adequately reflect the dynamics of contaminant availability to microbes in flow-through systems. This paper assesses the effects of interacting processes such as sorption, biodegradation, and transport on contaminant bioavailability, and the fraction of the bioavailable contaminant that is taken up by microbes. The evolution of the bioavailable and uptake fractions is studied in two ways. Firstly, column experiments are conducted in which the introduced contaminant (pentachlorophenol, PCP) can flow through the columns, be consumed by microorganisms, or be sorbed by a solid matrix. Secondly, a phenomenological model (Flow/Sink/Reservoir model) that illustrates the dynamic nature of bioavailability and quantifies the uptake fraction is developed, based on a flow balance. Results show that after 60 h of sorption-limited bioavailability, the microorganisms induce desorption, so that the sorbed pool becomes bioavailable and bioavailability is limited by the PCP injection rate. A conclusion is drawn that the aqueous-phase concentration is a poor indicator of contaminant bioavailability to microbes.
Related Concept Videos
Column Efficiency: Rate Theory
During elution, a solute molecule experiences numerous transitions between stationary and mobile phases, exhibiting irregular residence times in...
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
Pharmacokinetic–Pharmacodynamic Relationship: Model Components
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...

